Andrew Sheldon
Chief Executive Officer
Biotechnology
Medicago
Canada
Biography
Mr. Andrew J. Sheldon, also known as Andy, B.Sc (Hons), BAS, has been the President and Chief Executive Officer of Medicago Inc. since August 2003. Mr. Sheldon has thirty years of experience in the pharmaceutical industry. He serves as an Adviser at DiagnoCure Inc. He served as Vice President of Sales and Marketing of Shire Biologics. He was responsible for international expansion with European, American and Asian private partnership agreements. He was also responsible for distribution, customer service, maintenance and engineering at the Shire facility. He successfully negotiated the annual and pandemic influenza vaccine contract with the federal and provincial governments.
Research Interest
Bio tech products.